Chengdu SciMount Pharmatech Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2015-05-07
- Employees
- -
- Market Cap
- -
- Website
- http://www.xilinglab.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
- First Posted Date
- 2021-08-31
- Last Posted Date
- 2022-03-11
- Lead Sponsor
- Chengdu SciMount Pharmatech Co., Ltd.
- Target Recruit Count
- 8
- Registration Number
- NCT05029518
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, Australia
A Phase 1 Study of SMP-100 in Normal Healthy Volunteers
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2022-03-11
- Lead Sponsor
- Chengdu SciMount Pharmatech Co., Ltd.
- Target Recruit Count
- 53
- Registration Number
- NCT04296799
- Locations
- 🇦🇺
CMAX Clinical Research Pty Ltd, Adelaide, Australia
News
No news found